A 5-day-old neonate presents with multifocal seizures refractory to phenobarbital and levetiracetam. EEG shows burst-suppression. Brain MRI is normal. Metabolic workup is unremarkable. The team considers ordering genetic testing. What is the MOST important advantage of rapid trio WES over a singleton epilepsy gene panel in this scenario?